David Doster

David Doster is the Chief Executive Officer at Amsel Medical where David oversees the FDA-cleared SCureClamp with InterDigitation Occlusion Technology™. Prior to that, David served in various marketing and leadership roles at companies such as VSP Medical and AngioDynamics. David also has experience as the President/CEO at Innovative Aesthetic Technologies. David has received education from SUNY Adirondack, Burlington College, and UCLA's Anderson School of Business.